Butyrylcholinesterase antibody
-
- Target See all Butyrylcholinesterase (BCHE) Antibodies
- Butyrylcholinesterase (BCHE)
-
Reactivity
- Human, Dog
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This Butyrylcholinesterase antibody is un-conjugated
-
Application
- Western Blotting (WB), Flow Cytometry (FACS)
- Characteristics
- Homo sapiens butyrylcholinesterase (BCHE)
- Purification
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human BCHE (NP_000046) produced in HEK293T cell.
- Clone
- 1E1
- Isotype
- IgG1
- Top Product
- Discover our top product BCHE Primary Antibody
-
-
- Application Notes
- WB 1:500~2000, FLOW 1:100,
- Comment
-
The concentration of the product may vary between diferrent lots.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
-
- Target
- Butyrylcholinesterase (BCHE)
- Alternative Name
- BCHE (BCHE Products)
- Background
- Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.
- Molecular Weight
- 68.2 kDa
- Gene ID
- 590
- NCBI Accession
- NM_000055
- HGNC
- 590
- Pathways
- Peptide Hormone Metabolism
-